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Each year, influenza causes large numbers of deaths ([@R-2-1]*,*[@R-2-2]) and billions of dollars in direct medical costs and indirect costs from declines in productivity and worker absenteeism ([@R-2-3]). Influenza vaccines help prevent some costs, but the uptake of vaccination for influenza varies widely ([@R-2-4]), and effective vaccines may not be sufficient during influenza pandemics ([@R-2-5]). Use of antiviral drugs to mitigate the effects of seasonal and pandemic influenza is also subject to such limitations as cost considerations ([@R-2-6]), the need for adequate and timely delivery of antiviral drugs ([@R-2-7]), and concerns about the emergence of resistance ([@R-2-8]).

Nonpharmaceutical measures have been proposed as adjuncts for reducing the risk for influenza infection during pandemics and seasonal epidemics ([@R-2-9]). Studies suggest that physical interventions, such as handwashing, use of protective equipment (e.g., face masks), and social distancing measures, can effectively reduce transmission of respiratory viruses, including influenza ([@R-2-10]*,*[@R-2-11]).

A novel influenza A virus, pandemic (H1N1) 2009 virus, emerged in Mexico and the United States during 2009 and spread worldwide within months ([@R-2-12]*,*[@R-2-13]). A few studies have investigated transmission of pandemic (H1N) 2009 virus ([@R-2-14]*,*[@R-2-15]) and the public health interventions that could be used to mitigate its spread ([@R-2-16]). However, although some data are available from studies conducted in institutions and households ([@R-2-17]*,*[@R-2-18]), little is known about population-level risk factors for pandemic (H1N1) 2009 virus infection.

We investigated risk factors for serologically detected pandemic (H1N1) 2009 virus infection during the first wave of the epidemic in Singapore in 2009. Our study population was a prospective community-dwelling cohort of adults. Singapore is a tropical city-state and global travel hub in Southeast Asia with a population of 5.0 million persons. Singapore detected its first imported cases of pandemic (H1N1) 2009 in late May 2009 and subsequently experienced an epidemic wave lasting ≈12 weeks starting in late June, peaking during the first week of August, and subsiding by early September ([@R-2-19]*--*[@R-2-21]).

Methods
=======

Study Design and Recruitment
----------------------------

This prospective community cohort study was part of a larger study to determine serologic conversion to pandemic (H1N1) 2009 virus in different populations ([@R-2-22]). Community-dwelling adults 21--75 years of age were recruited from an existing cohort study. The Singapore Consortium of Cohort Studies is a long-term study conducted by the National University of Singapore to study gene--environment interactions in chronic diseases. In June 2009, ≈9,000 persons were participating in the Multi-ethnic Cohort, a subcohort of the Singapore Consortium of Cohort Studies. Participants for the Multi-ethnic Cohort were recruited through public outreach and referrals from existing cohort members. From among these 9,000 participants, we contacted 1,296 randomly selected participants, of whom 894 (69%) agreed to participate. All participants provided written consent, and the study received ethics review and approval from the Institutional Review Board of the National University of Singapore.

We obtained up to 3 blood samples from each participant. Banked blood samples were used for the baseline sample (sample 1); these samples were obtained during June 29, 2005--June 27, 2009, before widespread community transmission of pandemic (H1N1) 2009 virus in Singapore. Two additional blood samples were obtained: an intra-epidemic sample (sample 2) collected ≈4 weeks after the epidemic peaked (August 20--29, 2009) and a postepidemic sample (sample 3) collected ≈4 weeks after epidemic activity had subsided (October 6--11, 2009).

A baseline phone interview with a standardized questionnaire was conducted at recruitment, followed by interviews every 2 weeks throughout the epidemic period. We obtained the following information: sociodemographic and personal behavior, such as sex and ethnicity, history of vaccination for seasonal influenza, and smoking; measures of social interaction, including frequency of use of public transport, travel overseas, and extent of social mixing (e.g., visits to mass entertainment and sports venues); information about household size, ages of household members, and whether other persons in the household and workplace had symptoms of acute respiratory infections (ARIs); and new-onset respiratory and constitutional symptoms.

Laboratory and Statistical Methods
----------------------------------

Venous blood was obtained from participants, and serum was extracted on the same day. The hemagglutination-inhibition assay was performed according to standard protocols at the World Health Organization Collaborating Center for Reference and Research on Influenza in Melbourne, Victoria, Australia ([@R-2-22]). We defined seroconversion as a [\>]{.ul}4-fold increase in antibody titers between any successive pairs of blood samples (between sample 1 and sample 2 for participants who provided only 1 other sample in addition to baseline; and between samples 1 and 2 or between samples 2 and 3 for participants who provided 2 samples in addition to baseline). We considered participants to have seroconverted in the few instances in which titers increased [\>]{.ul}4-fold between samples 1 and 2 but not between samples 1 and 3.

The primary outcome of interest was seroconversion, and we evaluated other variables as independent predictors for seroconversion. Sociodemographic and biologic factors analyzed were age (calculated from date of birth obtained from the National Registration Identity Card \[NRIC\]), sex (obtained from NRIC), ethnicity (the 3 major ethnic groups in Singapore---Chinese, Malay, and Indian---and a category for other minorities, obtained from NRIC), self-reported dwelling type, self-reported vaccination [\>]{.ul}1× previously with the seasonal influenza vaccine (ever vs. never vaccinated), baseline antibody titer to pandemic (H1N1) 2009, and smoking behavior (current, former, and never). Measures of social mixing were self-reported overseas travel, self-reported frequency of use of public transport (bus and the Mass Rapid Transit metro system), and self-reported frequency of visits to the following places: mass entertainment venues (e.g., cinemas, stadiums, and theaters; shopping centers, markets, and supermarkets; restaurants, bars, clubs, and other eating or drinking establishments; places of worship; and other social gatherings with [\>]{.ul}10 persons). Except for overseas travel, these measures reflected lifestyle routine, and the behavior reported in the baseline interview was used to reduce any effect from reverse causality (e.g., avoiding particular activities or locations because of influenza symptoms). For the overseas travel variable, participants were classified as having ever traveled during the entire study period. We also examined the effects of the number of contacts in various age groups living in the same household and of exposure to contacts who were sick with ARI either at home or at work.

Bivariate analyses were performed for all variables, with a final multivariate model constructed with the key sociodemographic variables of age, ethnicity, sex, dwelling type (as a proxy for socioeconomic status), and variables of interest to our study (smoking, previous influenza vaccination, baseline antibody titer, travel and public transport use, working outside the home, contact with other persons at home or at work who had ARI, and number of household members), by using a Weibull proportional hazards model. We chose to work with a parametric survival analysis model rather than with the more familiar Cox semiparametric proportional hazards model because 1) event (seroconversion) times were all interval- or right-censored (rather than the more common combination of uncensored and right-censored observations) and 2) as a result of the short period of blood sampling, there were many tied interval endpoints, making exact methods (such as that of Kalbfleisch and Prentice \[[@R-2-23]\]) too exacting and approximations (such as those of Breslow \[[@R-2-24]\] or Efron \[[@R-2-25]\]) too approximate.

The study comprised participants from separate households and some from households where at least 1 other household member was also part of the study. Because influenza infection is transmissible, independence of outcomes cannot be assumed for persons from the same household. To reduce estimation errors, we randomly selected 1 person from each household for each regression analysis. We then repeated this selection process and analysis 1,000× to reduce the effect of chance variation resulting from the selection process. Reported hazard rates (HRs) refer to the mean HRs of all 1,000 iterations. Similarly, reported 95% confidence intervals (CIs) refer to the mean upper and lower 95% bounds from all 1,000 iterations. All p values reported are 2-tailed, with the significance level set at 0.05. We calculated goodness-of fit by using a modified version of the Hosmer-Lemeshow test ([@R-2-26]). The statistical package R version 2.9.2 ([@R-2-27]) was used for all analyses.

Results
=======

Of the 894 persons who agreed to participate in the study, 828 (93%) completed the baseline questionnaire. Baseline blood samples were available for all participants, sample 2 for 621 (69.5%) participants, and sample 3 for 689 (77.1%) participants. Three blood samples were available for 584 (65.3%) participants, and at least 2 samples were available for 727 (81.3%) persons. [Figure 1](#F-2-1){ref-type="fig"} shows the pandemic (H1N1) 2009 epidemic curve in Singapore and the recruitment process for this study. When we compared characteristics of the 727 participants who completed the study with the 828 who were enrolled at the start of the study (Table), we found them to be broadly similar. All subsequent analyses were performed on these 727 persons. Of these, 494 came from separate households and 233 came from 117 households where at least 1 other household member was also part of this study; selection for 1 member per household resulted in a sample size of 611 persons.

![A) Estimated pandemic (H1N1) 2009 curve, Singapore, June--September 2009. Data obtained from general practice sentinel data. Blue bars indicate number of influenza-like illness episodes per general practice per week. Red curve indicates estimated number of consults for pandemic (H1N1) 2009 per general practice per week. Orange bars indicate period of blood sample collection in the adult cohort ([@R-2-23]). B) Summary of recruitment numbers and dates of blood collection in the adult community cohort.](10-1270-F-2-1){#F-2-1}

###### Comparison of participants who provided follow-up blood samples with cohort at start of study of risk factors for pandemic (H1N1) 2009 seroconversion, Singapore, 2009\*

  Characteristic                                 Total, n = 828   Respondents, n = 727
  ---------------------------------------------- ---------------- ----------------------
  Age, y, mean (SD)                              43.4 (12.0)      43.6 (11.8)
  Age group, y                                                    
  20--29                                         149 (18.0)       124 (17.1)
  30--39                                         131 (15.8)       113 (15.5)
  40--49                                         285 (34.4)       260 (35.8)
  50--59                                         175 (21.1)       155 (21.3)
  \>60                                           88 (10.6)        75 (10.3)
  Sex                                                             
  F                                              482 (58.2)       432 (59.4)
  M                                              346 (41.8)       295 (40.6)
  Ethnicity                                                       
  Chinese                                        94 (11.4)        90 (12.4)
  Malay                                          374 (45.2)       331 (45.5)
  Indian                                         353 (42.6)       299 (41.1)
  Other                                          7 (0.9)          7 (1.0)
  Dwelling type                                                   
  \<3-room public housing                        202 (24.4)       177 (24.3)
  4-room public housing                          360 (43.5)       310 (42.6)
  5-room public housing or private housing       266 (32.1)       240 (33.0)
  Smoking                                                         
  Current smoker                                 181 (21.9)       149 (20.5)
  Nonsmoker/former smoker                        647 (78.1)       578 (79.5)
  No. household members                                           
  1                                              580 (70.1)       496 (68.2)
  2                                              208 (25.1)       195 (26.8)
  3                                              36 (4.4)         33 (4.5)
  4                                              4 (0.5)          3 (0.4)
  Self-reported previous influenza vaccination                    
  No                                             751 (90.7)       662 (91.1)
  Yes                                            77 (9.3)         65 (8.9)
  Employment outside the home                                     
  No                                             308 (37.2)       277 (38.0)
  Yes                                            520 (62.8)       450 (62.0)
  Baseline antibody titer                                         
  Mean (SD)                                      0.22 (0.71)      0.25 (0.75)
  By age group, y                                                 
  20--29                                                          0.48 (1.06)
  30--39                                                          0.19 (0.58)
  40--49                                                          0.17 (0.59)
  50--59                                                          0.28 (0.84)
  \>60                                                            0.12 (0.52)
  Public transport                                                
  Seldom                                         294 (35.5)       249 (34.3)
  Frequent                                       534 (64.5)       478 (65.7)

\*Values are no. (%) except as indicated. Respondents are participants who provided at least 1 blood sample in addition to that obtained at baseline.

In bivariate analyses, seroconverters were younger, more likely to smoke, and more likely to have traveled outside Singapore than were nonseroconverters ([Table A1](#T-2-A.1){ref-type="table"}). Seroconverters also were more likely to be of Malay ethnicity and to have more household members 5--19 years of age; however, p values for these 2 variables were just \>0.05.

We assessed the frequency of activities and visits to a variety of public places, including use of public transport, during a 14-day period at baseline among the 727 participants and the proportion in each frequency group who seroconverted by the end of the study ([Figure 2](#F-2-2){ref-type="fig"}; [Technical Appendix](#SD1){ref-type="local-data"}Table 1). The frequencies of activities and visits to public venues were not associated with seroconversion. More frequent use of public transport appeared to be associated with higher seroconversion rate. The proportion of seroconverters in the "never" and "once/twice" categories were similar, as were those in the "several times" and "daily/almost daily" categories. We dichotomized this variable into frequent use (i.e., participants reporting several times or daily/almost daily use of public transport during the preceding 14 days at baseline) and seldom use (participants reporting no use or use once or twice during the preceding 14 days. Frequent users of public transport were more likely to seroconvert; however, this finding was not statistically significant.

![Study of seroconversion for pandemic (H1N1) 2009 virus, Singapore, June--September 2009. Public places were as follows: mass entertainment venues (e.g., cinemas, stadiums, and theaters; shopping centers, markets, and supermarkets; restaurants, bars, clubs, and other eating or drinking establishments; places of worship; and other social gatherings with [\>]{.ul}10 persons. Horizontal lines denote error bars for the estimates.](10-1270-F-2-2){#F-2-2}

In multivariate analysis ([Table A1](#T-2-A.1){ref-type="table"}), men were more likely than women to seroconvert (mean HR 2.23, 95% CI 1.26--3.93). Malays were more likely than Chinese to seroconvert (mean HR 2.67, 95% CI 1.04--6.91). Working outside the home and not having a work contact with ARI symptoms was associated with lower likelihood of seroconversion (mean HR 0.39, 95% CI 0.21--0.7); however, this decreased risk was not seen in workers who reported a work contact with ARI symptoms. Frequent use of public transport (mean HR 1.81, 95% CI 1.05--3.09) and travel out of the country (mean HR 1.76, 95% CI 1.11--2.78) also were associated with a higher risk for seroconversion, whereas high baseline antibody titers to pandemic (H1N1) 2009 virus were associated with lower risk for seroconversion (mean HR 0.5, 95% CI 0.27--0.94). The number of household members 5--19 years of age was marginally associated with increased risk for seroconversion (mean HR 1.17, 95% CI 0.95--1.43 for each additional member, compared with not having a household member in that age group), although the p value was not significant. There was good fit for the multivariate model (p = 0.625).

We repeated analyses ([Technical Appendix](#SD1){ref-type="local-data"} Tables 2, 3) by using a logistic regression model for all 727 participants. Odds ratios (ORs) were broadly similar to the corresponding HRs when Weibull regression was used, with significant associations obtained for foreign travel, public transport use, high baseline antibody titers, sex, ethnicity and employment outside the home ([Technical Appendix](#SD1){ref-type="local-data"} Tables 2, 3). These findings suggested that results are robust to the choice of modeling framework.

We investigated whether the association between seroconversion and foreign travel was greater in the earlier than in the later part of the outbreak by considering the subset of participants who provided 3 blood samples. We defined early seroconverters as participants who seroconverted between samples 1 and 2 and late seroconverters as those who converted between samples 2 and 3, and we investigated the estimated risk associated with foreign travel in logistic regression. After adjustment, the OR for foreign travel among early seroconverters was 2.06 (95% CI 1.25--3.55), whereas that for late seroconverters was 1.71 (95% CI 0.63--4.68).

Discussion
==========

Understanding the factors that influence the risk for influenza infection will permit development of rational response strategies to reduce transmission. Although studies have been conducted of household and institutional risk factors ([@R-2-14]*,*[@R-2-17]*,*[@R-2-18]*,*[@R-2-28]) for pandemic (H1N1) 2009 virus transmission, few data are available on risk factors in the general population. Through the use of a population-based cohort design, our study suggests that several factors are associated with pandemic (H1N1) 2009 infection.

A history of travel abroad was associated with increased risk for seroconversion. Self-reports obtained throughout the outbreak were used, and this result could have been subject to reverse causation; i.e., symptomatic persons may have reduced their frequency of travel. However, this bias, if present, would have resulted in a lower estimate of the true risk and therefore cannot explain the association observed. Whether the increased risk for seroconversion associated with overseas travel results from prolonged close proximity with infected travelers in airports and on airplanes or to transmission within other countries is unclear. Compared with the OR for early seroconverters, the OR for foreign travel in late seroconverters was not attenuated. If the risks associated with foreign travel resulted primarily from increased likelihood of transmission overseas, then we would expect the risk to be high during the start of an epidemic and drop substantially as local transmission increased. Our results imply that other explanations may be relevant, such as increased infection from prolonged close proximity with other infected persons during travel (e.g., on an airplane) or to increased use of public transport, such as buses or subway systems, during travel. A recent publication based on a retrospective cohort study of confirmed pandemic (H1N1) 2009 infection in persons returning from Mexico to New Zealand on a commercial airliner suggested a measureable risk associated with being on an airliner with infected persons ([@R-2-29]). Further research is needed to understand the association between foreign travel and seroconversion. Although total restriction on global travel will not be feasible and is unlikely to prevent importation of infectious cases ([@R-2-30]), such measures as travel advisories that promote personal hygiene and advise passengers to seek medical assistance promptly if symptoms develop might mitigate the effect of international travel on influenza transmission ([@R-2-9]*,*[@R-2-31]*,*[@R-2-32]).

The local use of public transport was significantly associated with increased risk for seroconversion, even after adjustment. Confounding is unlikely to explain this association. Public transport in the local context involves close contact with a large number of persons, often for prolonged periods. Mathematical modeling studies have suggested that social distancing and reduction of mass gatherings are critical for preventing influenza spread ([@R-2-9]). Although shutting down public transport systems is not possible without severe socioeconomic impact, other measures, such as reduction of crowding in public transport systems; better air circulation; and advice on personal hygiene etiquette and measures, including face mask use, may help to reduce transmission. Further studies are needed to characterize the mechanisms of influenza and respiratory virus transmission within public transport systems.

Compared with participants who did not have a job or worked from home, persons who worked away from home had a lower risk for seroconversion, but this risk was observed only among those who reported that no one in their workplace had symptoms of ARI. These findings suggest that transmission within the household may be more relevant than in the workplace. One possible explanation is that persons who do not work may be more involved in childcare activities at home. One study found that spending long periods exposed to a sick index patient is a risk factor for infection ([@R-2-17]), and other studies have implicated children, especially those that are attending school, as a source of influenza transmission ([@R-2-33]*,*[@R-2-34]). Our study suggests that having a school-aged household member (5--19 years of age) increased risk for seroconversion (however, in multivariate analyses, the effect was attenuated and was not statistically significant). Interventions that target schoolchildren, such as vaccination and school closures, may reduce infection among other family members.

Household studies, such as that by Cauchemez et al. ([@R-2-14]), have shown that increasing household size reduced the probability of transmission by each index patient. The amount of time spent by any 1 person in close contact with an index patient is most likely to be lower in larger households. However, such studies do not assess the aggregate risk when \>1 household members become infected during an outbreak. Our study suggests that having more household members in the 5--19-year age group increases overall risk for seroconversion during a pandemic, a finding that is biologically plausible because every household member is at risk for infection (and subsequent transmission) during an outbreak.

Having a contact with ARI at home was not associated with increased risk for seroconversion. This finding might result from the low specificity and sensitivity of ARI as a marker for exposure to pandemic (H1N1) 2009 because other viral causes of ARI (including other influenza strains) were cocirculating in substantial proportion in Singapore during the pandemic ([@R-2-19]). Infections also could have been transmitted by asymptomatic infected persons---indeed, 27% of persons in our study who seroconverted did not have any ARI symptoms throughout the study period.

Baseline antibody titers were associated with lower seroconversion rates. Older participants, especially those [\>]{.ul}60 years of age, appeared to have a lower risk for seroconversion (however, this finding was not statistically significant after multivariate adjustment). Other studies also have reported lower rates of infection among older persons ([@R-2-35]). Some groups ([@R-2-36]) have proposed that previously acquired immunity might explain the protection, although in our study, older participants did not have higher levels of measureable antibodies to pandemic (H1N1) 2009 virus. Other factors, such as lower levels of social contact among elderly persons, might explain the observation.

Men were more likely than women, and Malays were more likely than Chinese, to seroconvert. Although the association with male sex has not previously been reported, a study of the 1957 influenza pandemic in Singapore also suggested higher infection rates in Malays ([@R-2-37]). Unmeasured sociocultural and behavioral factors might explain these observations, and further studies are needed to confirm these observations and to understand the basis for the association.

Our study did not find any effect of the frequency of visits to public venues on the risk for seroconversion (results not shown). We could not obtain accurate estimates of the length of time spent at each venue, the number of persons with whom each participant had contact during the visit, and the proximity and intensity of contact. Studies that capture such detail would be useful to quantify the relative risks for various activities and visits to different public venues during pandemics. Such a study would have public health policy implications because one option for social distancing is to close public venues, such as cinemas and theaters, an option taken by the authorities in Mexico during the early stages of the pandemic ([@R-2-38]).

Our study had other limitations. We used data obtained at baseline because these would not be subject to reverse causation. However, behavior recorded at baseline might not reflect actual behavior during the outbreak. We were unable to study the effect of personal hygiene measures, such as use of face masks and handwashing, because of the complexity of measuring these factors by using questionnaires every 2 weeks.

Our prospective cohort study suggests avenues for further research into public health interventions for influenza epidemics. We showed that overseas travel and use of public transport were significantly associated with increased risk for seroconversion, and these offer potential areas for public health intervention, such as travel restriction, social distancing, and personal protection measures. Additional research is required to understand the reasons behind the increased risks associated with demographic factors of sex and ethnicity.
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###### Bivariate and multivariate analyses of factors associated with seroconversion to pandemic (H1N1) 2009 in a cohort of community-dwelling adults, Singapore, 2009\*

  ---------- ----------------------- ------------------------------ -------------------- -- -----------------------
  Variable   Seroconverted, n = 98   Did not seroconvert, n = 629   Bivariate analysis      Multivariate analysis
  ---------- ----------------------- ------------------------------ -------------------- -- -----------------------

  Mean HR (95% CI)†                                                     Mean p value‡                Mean HR (95% CI)†       Mean p value‡                              
  --------------------------------------------------------------------- --------------- ------------ ----------------------- --------------- -- ----------------------- -----------
  Age, y                                                                                                                                                                
  Mean                                                                  41.14           44.05        0.79 (0.65--0.95)       0.034                                      
  Median                                                                43              45                                                                              
  Range                                                                 21--64          21--82                                                                          
  Age group, y                                                                                                                                                          
  20--29                                                                21 (16.9)       103 (83.1)   1.00                                       1.00                    
  30--39                                                                16 (14.2)       97 (85.8)    0.84 (0.42--1.67)       0.627              1.10 (0.52--2.36)       0.772
  40--49                                                                42 (16.2)       218 (83.8)   0.78 (0.44--1.39)       0.423              0.94 (0.46--1.94)       0.780
  50--59                                                                15 (9.7)        140 (90.3)   0.51 (0.25--1.03)       0.096              0.63 (0.29--1.34)       0.259
  [\>]{.ul}60                                                           4 (5.3)         71 (94.7)    0.25 (0.07--0.86)       0.054              0.31 (0.09--1.12)       0.105
  Sex                                                                                                                                                                   
  F                                                                     52 (12.0)       380 (88.0)   1.00                                       1.00                    
  M                                                                     46 (15.6)       249 (84.4)   1.48 (0.95--2.29)       0.128              **2.23 (1.26--3.93)**   **0.024**
  Ethnicity                                                                                                                                                             
  Chinese                                                               6 (6.7)         84 (93.3)    1.00                                       1.00                    
  Malay                                                                 56 (16.9)       275 (83.1)   **2.76 (1.14--6.69)**   **0.054**          **2.67 (1.04--6.91)**   **0.075**
  Indian                                                                34 (11.4)       265 (88.6)   1.55 (0.61--3.91)       0.390              1.94 (0.74--5.09)       0.218
  Other                                                                 2 (28.6)        5 (71.4)     2.19 (0.26--18.54)      0.482              2.65 (0.30--23.52)      0.400
  Dwelling type                                                                                                                                                         
  ≤3-room public housing                                                21 (11.9)       156 (88.1)   1.00                                       1.00                    
  4-room public housing                                                 51 (16.5)       259 (83.5)   1.58 (0.88--2.83)       0.173              1.39 (0.75--2.61)       0.348
  5-room public housing or private housing                              26 (10.8)       214 (89.2)   1.08 (0.57--2.06)       0.763              1.01 (0.50--2.05)       0.800
  Smoking                                                                                                                                                               
  Current smoker                                                        30 (20.1)       156 (79.1)   1.00                                       1.00                    
  Nonsmoker/former smoker                                               68 (11.8)       156 (88.1)   **0.52 (0.32--0.83)**   **0.027**          0.64 (0.35--1.14)       0.171
  Household members                                                                                                                                                     
  1                                                                     63 (12.7)       433 (87.3)   1.00                                                               
  2                                                                     33 (16.9)       162 (83.1)   1.34 (0.78--2.29)       0.371                                      
  3                                                                     2 (6.1)         31 (93.9)    0.89 (0.17--4.98)       0.666                                      
  4                                                                     0               3 (100.0)                            0.400                                      
  Self-reported previous influenza vaccination                                                                                                                          
  No                                                                    88 (13.3)       574 (86.7)   1.00                                       1.00                    
  Yes                                                                   10 (15.4)       55 (84.6)    1.06 (0.51--2.22)       0.758              1.13 (0.51--2.48)       0.721
  Employment outside the home                                                                                                                                           
  No                                                                    42 (15.2)       235 (84.8)   1.00                                       1.00                    
  Yes, without anyone at work having ARI symptoms during study period   39 (11.2)       310 (88.8)   0.66 (0.41--1.08)       0.142              **0.39 (0.21--0.70)**   **0.013**
  Yes, with anyone at work having ARI symptoms during study period      17 (16.8)       84 (83.2)    1.18 (0.65--2.17)       0.605              0.89 (0.44--1.80)       0.715
  Baseline antibody titer                                                                                                                                               
  Mean                                                                  0.082           0.272        0.54 (0.29--1.00)       0.086              **0.50 (0.27--0.94)**   **0.059**
  Median                                                                0               0                                                                               
  No. household members 0--4 y                                                                                                                                          
  Mean                                                                  0.204           0.291        0.79 (0.52--1.20)       0.287              0.71 (0.45--1.12)       0.166
  Median                                                                0               0                                                                               
  Range                                                                 0--3            0--3                                                                            
  No. household members 5--19 y                                                                                                                                         
  Mean                                                                  1.57            1.22         **1.19 (1.02--1.40)**   **0.064**          1.17 (0.95--1.43)       0.170
  Median                                                                1.0             1                                                                               
  Range                                                                 0--6            0--5                                                                            
  No. household members \>19 y                                                                                                                                          
  Mean                                                                  3.33            3.10         1.14 (0.98--1.33)       0.131              1.13 (0.94--1.36)       0.216
  Median                                                                3               3                                                                               
  Range                                                                 1--8            1--9                                                                            
  Household contact with ARI symptoms during course of study                                                                                                            
  No                                                                    72 (14.4)       428 (85.6)   1.00                                       1.00                    
  Yes                                                                   26 (11.5)       201 (88.5)   0.75 (0.46--1.22)       0.279              0.71 (0.41--1.21)       0.243
  Travel out of Singapore during study period                                                                                                                           
  No                                                                    50 (10.2)       438 (89.8)   1.00                                       1.00                    
  Yes                                                                   48 (20.1)       191 (79.9)   **2.10 (1.35--3.25)**   **0.012**          **1.76 (1.11--2.78)**   **0.044**
  Public transport                                                                                                                                                      
  Seldom                                                                26 (10.4)       223 (89.6)   1.00                                       1.00                    
  Frequent                                                              72 (15.1)       406 (84.9)   1.61 (0.96--2.70)       0.106              **1.81 (1.05--3.09)**   **0.062**

\*Values are no. (%) except as indicated. Multivariate model included all variables listed; goodness-of-fit was 0.625. **Boldface** indicates significance. HR, hazard rate; CI, confidence interval; ARI, acute respiratory infection. †Calculated as the mean HR of 1,000 separate analyses, where each analysis comprised 610 persons from different households; 1 person was randomly selected from households that had \>1 member in the study. The means of the upper and lower bound of the 95% CIs were computed for each variable. ‡The mean of the p estimate from the 1,000 iterations was computed for each variable.
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**1. You are a member of a public health task force with the assignment to reduce the impact of influenza on your community. The task force director asks you to investigate risk factors for infection with pandemic (H1N1) 2009.Which of the following demographic variables was associated with a higher risk for pandemic (H1N1) 2009 seroconversion?**A. Age between 20 and 29 yearsB. Age older than 60 yearsC. Male sexD. 3-room or smaller dwelling**2. Which of the following factors most likely reduced the risk for pandemic (H1N1) 2009 seroconversion?**A. Malay ethnicityB. More international travelC. Working outside of the homeD. Regular tea consumption**3. Which of the following public health interventions may be most effective in preventing the spread of pandemic (H1N1) 2009?**A. Limiting theater seating to every other seatB. Closing restaurantsC. Improving air circulation on public transportationD. Limiting seating at places of worship**4. Which of the following laboratory values was associated with a reduced rate of pandemic (H1N1) 2009 seroconversion?**A. High baseline antibody titers to pandemic (H1N1) 2009B. Low baseline antibody titers to pandemic (H1N1) 2009C. Normal serum glucose levelsD. High serum white blood cell counts
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